谈论安慰剂:对患者对开放式安慰剂在临床实践中的实施态度的定性研究
Antje Frey Nascimento1, Berfin Bakis1, Jens Gaab1
1Division of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, Switzerland.
Frontiers in psychology
|August 18, 2025
概括
开放标签安慰剂 (OLP) 显示出在伦理上利用安慰剂效应的希望. 患者对OLP的态度各不相同,对信任和实际实施的担忧需要进一步探索,以获得成功的临床整合.
科学领域:
- 医学伦理 医学伦理
- 精神病体医学是一种精神病体医学.
- 临床心理学 临床心理学
背景情况:
- 开放标签安慰剂 (OLP) 证明了有效性和安全性,与利用安慰剂效应的伦理原则保持一致.
- 患者的接受和观点对于将OLP等新型干预措施实施到临床实践中至关重要.
- 定性研究对于了解患者的态度,感知障碍和OLP的好处至关重要.
研究的目的:
- 调查患者的态度,担忧和关于开放标签安慰剂 (OLP) 临床实施的想法.
- 探索患者对OLP干预措施在医疗机构的可行性和接受性的观点.
- 确定将OLP纳入常规临床实践的潜在障碍和促进者.
主要方法:
- 进行了三次在线焦点小组讨论 (FGDs) 与患有慢性背痛,慢性偏头痛或化疗诱导的恶心的成年患者.
- 在数据分析的社会构造主义框架内,利用了带有诱导-演的混合方法的反思性主题分析.
- 从瑞士巴塞尔大学医院的门诊诊所招募了参与者.
主要成果:
- 确定了五个关键主题:"安慰剂:有希望但有风险"",OLP的接受取决于无数"",值得信赖,但欺骗可能是必要的"",在没有安慰剂的情况下利用安慰剂效应"和"从长椅到床边:OLP的临床转移".
- 揭示了患者的不同态度,不同程度的接受,并对OLP使用的伦理和实际方面表示担忧.
- 突出了关于 OLP 实施,前提条件和医疗保健提供者的作用的矛盾.
结论:
- 患者和公众的参与对于OLP干预措施的成功实施至关重要.
- 对于OLP及其实际应用的态度在患者群体之间甚至在相同的临床条件内都存在差异.
- 解决伦理考虑和实际挑战对于在临床实践中广泛采用OLP至关重要.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
相关概念视频
Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
